JPRN-jRCT2080221771UnknownPhase 1
Drug-drug interaction study of SMP-508 and sitagliptin.
Trial Snapshot
- Phase
- Phase 1
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to <= 40age old (—)
- Sex
- Male
Inclusion Criteria
- •Healthy adult male volunteers
- •Inclusion criteria
- •- Subjects who provided written informed consent to participate in the study.
- •- Subjects whose body weight are between 50.0 and 80.0 kg and whose body mass index (BMI) are 18.5 to 25.0 {BMI = body weight (kg) / [height (m)]2}
Exclusion Criteria
- •Exclusion criteria
- •- Subjects with a history of drug allergies.
- •- Subjects with any alcohol abuse.
Investigators
Similar Trials
Completed
Phase 1
Drug-drug interaction study of NS-580 in Healthy male subjects (Phase I Study)JPRN-jRCT2071220031Higashioka Masaya60
Active, not recruiting
Phase 1
Drug-drug interactions study of TAS-115 in patients with solid tumorsJPRN-jRCT2031210372Motoo Yoshiharu18
Completed
Phase 1
Drug-drug interaction study of S-217622COVID-19JPRN-jRCT2031210595agata Tsutae14
Completed
Phase 1
Drug-Drug Interaction Study in Healthy Japanese Adult SubjectsCentral Retinal Artery OcclusionJPRN-jRCT2031210444Ohtori Akira24
Active, not recruiting
Phase 1
INTERACCIONES FARMACOLÓGICAS ENTRE LA SILIMARINA Y DARUNAVIR/RITONAVIRInfección por el VIH.MedDRA version: 13Level: LLTClassification code 10008922Term: Infección crónica con VIHEUCTR2010-021159-25-ESFundació Lluita contra la Sida15